Live Breaking News & Updates on Neurological Movement Disorders Market

Stay updated with breaking news from Neurological movement disorders market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Neurological Movement Disorders Market Size to Grow at a CAGR of 9.80% from 2021 to 2030


Share:
Pune, India, June 01, 2021 (GLOBE NEWSWIRE) The global neurological movement disorders market has been estimated to reach a value of USD 12,800 million in 2021 and is projected to grow at a CAGR of 9.80% during the forecast period from 2021 to 2030.
Neurological movement disorders are conditions that impair one s ability to generate and regulate movement. This condition predominantly affects the brain, spinal cord, as well as nerves in the body, resulting in cerebrovascular diseases, adult degenerative diseases, and other complications. The key growth drivers of the movement disorder market are the development of efficient and advanced technology, growing prevalence of neurodegenerative disorders, patent expiration of many blockbuster drugs, and the advent of new technologies globally. ....

United States , United Kingdom , Merz Pharma , Asia Pacific , Resofus Alomar , Carbidopa Levodopa , Impact On Global Neurological Movement Disorders Market , Boston Scientific Corporation , Movement Disorder , Research Laboratories Academic Institutes , Neurological Movement Disorders Market , Surgical Centre Association , Neuropace Inc , Technology Internal Neuromodulation , Co Ltd , Abbott Laboratories Inc , National Organization For Rare Disorders , National Association For Rare Diseases , Surgical Centers , Clinics Ablation Centers , Neurological Society Of India , Surgical Center , Insightec Ltd , Global Neurological Movement Disorders Market , Sample Copy , Neurological Society ,